Results 101 to 110 of about 31,788 (164)

Clinical and Genetic Characterization of Russian Patients with von Hippel-Lindau Syndrome. [PDF]

Int J Mol Sci
Mikhaylenko DS, Vasserman NN, Kuryakova NB, Kuznetsova EB, Gorban NA, Stepanova AA, Shchagina OA, Polyakov AV, Zaletaev DV, Kutsev SI, Strelnikov VV.   +10 more
europepmc   +1 more source

Beyond hypoxia and ccRCC: the expanding universe of VHL novel targets and next-generation therapeutics. [PDF]

Biomark Res
Deng R, Wang B, Zou M, Mao K, Shang J, Qiu J, Zhou J, Xu H, Ma X, Wang Y, Cai L, Gong K.   +11 more
europepmc   +1 more source

Regenerative potential of von Hippel-Lindau tumor suppressor protein. [PDF]

World J Biol Chem
Kanno H, Nakahara K.
europepmc   +1 more source

Von Hippel-Lindau syndrome presenting as a lateral ventricular space-occupying lesion: a case report. [PDF]

Front Oncol
Liu L, Chen Y, Zhang Z, Zhou G.
europepmc   +1 more source

Dissecting Hypoxia Inducible Factor-Driven High Bone Mass Phenotype in Mice Lacking Osteocytic Von Hippel-Lindau. [PDF]

JBMR Plus
Pantoja AP, Mendoza SV, Murugesh DK, Christiansen BA, Loots GG, Genetos DC, Yellowley CE.   +6 more
europepmc   +1 more source

4-2 VHL-Recruiting PROTAC Inhibits the Growth and Migration of Triple Negative Breast Cancer Cells by Triggering Pyroptosis Through Fas-Mediated IL-17 Signaling. [PDF]

Drug Dev Res
Wang Q, Huang Q, Ou H, Huang T, He Y, Li P.   +5 more
europepmc   +1 more source

Case Report: The cystic masquerade in type 1 Von Hippel-Lindau disease: coexisting clear cell renal cell carcinoma and an imaging-suspected pancreatic neuroendocrine tumor. [PDF]

Front Oncol
Yang D, Sun Y, Zhang S.
europepmc   +1 more source

Navigating the landscape of targeted therapies for renal cell carcinoma in the era of precision medicine (Review). [PDF]

Mol Med Rep
Cui H, Song J, Yang P, Zhang Z, Liu Y, Zhang G, Tian A, Che J, Liu Y, Sun H, Xu Y.   +10 more
europepmc   +1 more source

FBXO22 is a promising E3 ubiquitin ligase for targeted protein degradation. [PDF]

Curr Opin Chem Biol
Liu T, Robertson KC, McGowan AS, Thompson RE, James LI, Brown NG.   +5 more
europepmc   +1 more source

Recent advances in etiology and treatment of von Hippel-Lindau Disease (VHLD). [PDF]

Cancer Metastasis Rev
Pirestani S, Nicolas E, Broadrup RL, Clapper ML, Golemis E.   +4 more
europepmc   +1 more source